Drug Profile


Alternative Names: GAP-486; WAY 214486; ZP 123

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Zealand Pharma
  • Class Antiarrhythmics
  • Mechanism of Action Gap junction modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Atrial fibrillation; Ventricular arrhythmias

Most Recent Events

  • 21 Dec 2005 Data presented at the 78th Scientific Sessions of the American Heart Association (AHA-2005) have been added to the pharmacokinetics and Arrhythmias pharmacodynamics sections
  • 09 Nov 2005 Phase-I clinical trials in Ventricular arrhythmias in Denmark (unspecified route)
  • 01 Jun 2005 Phase-II clinical trials in Ventricular arrhythmias in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top